FIELD: medicine.
SUBSTANCE: invention relates to medicine, in particular to rheumatology, pulmonology and therapy. The set of diagnostic markers is determined: the number of surfaces of the lower/upper extremities with revealed diffuse inflammatory lesions of the skin and subcutaneous adipose tissue; the number of erymatous nodes; the number of joint arthritis; the concentration of C-reactive protein. Based on the data obtained according to the original formula, the probability of the X-ray stage of acute sarcoidosis is determined.
EFFECT: method makes it possible to carry out an express assessment of the X-ray stage of acute sarcoidosis associated with septal panniculitis at any stage of the patient's observation.
1 cl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF TREATING IDIOPATHIC NEUTROPHIL LOBULAR PANNICULITIS | 2020 |
|
RU2729996C1 |
| METHOD FOR ASSESSING THE RISK OF JOINT EROSIONS IN PATIENTS WITH PSORIATIC ARTHRITIS | 2022 |
|
RU2791661C1 |
| METHOD OF TREATMENT OF NODULAR ERYTHEMA | 1994 |
|
RU2108799C1 |
| METHOD OF TREATING LOBULAR PANNICULITIS - LIPODERMATOSCLEROSIS PATIENTS | 2019 |
|
RU2701392C1 |
| METHOD FOR RAPID ASSESSMENT OF AXIAL SKELETON INVOLVEMENT RISK IN EARLY FORMS OF PSORIATIC ARTHRITIS | 2020 |
|
RU2724276C1 |
| METHOD FOR DETERMINING INDICATIONS TO BEGINNING OF RECEPTION OF GENETIC ENGINEERING BIOLOGICAL PREPARATIONS WITH INEFFECTIVENESS OF BASIC ANTI-INFLAMMATORY PREPARATIONS IN EARLY FORMS OF PSORIATIC ARTHRITIS | 2020 |
|
RU2731807C1 |
| DIAGNOSTIC TECHNIQUE FOR AUTOIMMUNE INFLAMMATION IN NEWLY DIAGNOSED SARCOIDOSIS PATIENTS | 2019 |
|
RU2739377C1 |
| METHOD FOR EVALUATING ANTIOXIDATION PROTECTION STATE IN LUNG DISEASE PATIENTS (SARCOIDOSIS, FIBROSING ALVEOLITIS, LARVAL PARAGONIMIASIS) | 1998 |
|
RU2152620C1 |
| METHOD FOR DETERMINING PSORIATIC ARTHRITIS ACTIVITY | 2020 |
|
RU2746884C1 |
| METHOD OF PREDICTING ACHIEVEMENT OF MINIMAL DISEASE ACTIVITY DURING THERAPY IN TREATMENT OF PATIENTS WITH PSORIATIC ARTHRITIS | 2022 |
|
RU2808550C1 |
